FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Axel Glasmacher

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
Katharina Schwamborn; Axel Glasmacher; Marcus Gorschlüter; Ingo G H Schmidt-Wolf
Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma.
Richard F Schlenk; Konstanze Döhner; Silja Mack; Michael Stoppel; Franz Király; K Götze; Frank Hartmann; Heinz A Horst; Elisabeth Koller; Andreas Petzer; Wolfgang Grimminger; Guido Kobbe; Axel Glasmacher; Hans Salwender; Heinz Kirchen; Detlef Haase; Stephan Kremers; Axel Matzdorff; Axel Benner; Hartmut Döhner
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Marie von Lilienfeld-Toal; Susanne Frank; Christiane Leyendecker; Sylvia Feyler; Sarah Jarmin; Ruth Morgan; Axel Glasmacher; Angela Märten; Ingo G H Schmidt-Wolf; Peter Brossart; Gordon Cook
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Axel Glasmacher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Katharina Schwamborn; Axel Glasmacher; Marcus Gorschlüter; Ingo G H Schmidt-Wolf
Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma.
German medical science : GMS e-journal 2011;9():Doc26.
2010: Richard F Schlenk; Konstanze Döhner; Silja Mack; Michael Stoppel; Franz Király; K Götze; Frank Hartmann; Heinz A Horst; Elisabeth Koller; Andreas Petzer; Wolfgang Grimminger; Guido Kobbe; Axel Glasmacher; Hans Salwender; Heinz Kirchen; Detlef Haase; Stephan Kremers; Axel Matzdorff; Axel Benner; Hartmut Döhner
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4642-8.
2010: Marie von Lilienfeld-Toal; Susanne Frank; Christiane Leyendecker; Sylvia Feyler; Sarah Jarmin; Ruth Morgan; Axel Glasmacher; Angela Märten; Ingo G H Schmidt-Wolf; Peter Brossart; Gordon Cook
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
Cancer immunology, immunotherapy : CII 2010;59(6):829-39.
2010: Corinna Hahn-Ast; Axel Glasmacher; Sara Mückter; Andrea Schmitz; Anja Kraemer; Günter Marklein; Peter Brossart; Marie von Lilienfeld-Toal
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006.
The Journal of antimicrobial chemotherapy 2010;65(4):761-8.
2010: Annika Juergens; Hendrik Pels; Sabine Rogowski; Klaus Fliessbach; Axel Glasmacher; Andreas Engert; Marcel Reiser; Volker Diehl; Marlies Vogt-Schaden; Gerlinde Egerer; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Udo Bode; Ulrich Herrlinger; Michael Linnebank; Martina Deckert; Rolf Fimmers; Ingo G H Schmidt-Wolf; Uwe Schlegel
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
Annals of neurology 2010;67(2):182-9.
2009: Marie von Lilienfeld-Toal; Lutz E Lehmann; Ansgar D Raadts; Corinna Hahn-Ast; Katjana S Orlopp; Günter Marklein; Ingvill Purr; Gordon Cook; Andreas Hoeft; Axel Glasmacher; Frank Stüber
Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia.
Journal of clinical microbiology 2009;47(8):2405-10.
2009: Michael Linnebank; Susanna Moskau; Annika Jürgens; Matthias Simon; Alexander Semmler; Katjana Orlopp; Axel Glasmacher; Christopher Bangard; Marlies Vogt-Schaden; Horst Urbach; Ingo G H Schmidt-Wolf; Hendrik Pels; Uwe Schlegel
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
Neuro-oncology 2009;11(1):2-8.
2008: Katjana Orlopp; Marie von Lilienfeld-Toal; Günter Marklein; S M Reiffert; A Welter; Corinna Hahn-Ast; I Purr; Marcus Gorschlüter; Ernst Molitor; Axel Glasmacher
False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
The Journal of antimicrobial chemotherapy 2008;62(5):1109-12.
2008: Marie von Lilienfeld-Toal; Corinna Hahn-Ast; Kerstin Furkert; Florian Hoffmann; Ralph Naumann; Ralf Bargou; Gordon Cook; Axel Glasmacher
A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma.
European journal of haematology 2008;81(4):247-52.
2008: Peter Kaskel; Silja Tuschy; Alexander Wagner; Christian Bannert; Oliver A Cornely; Axel Glasmacher; Hans-Peter Lipp; Andrew J Ullmann
Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting.
Annals of hematology 2008;87(4):311-9.
2008: Corinna Hahn-Ast; Axel Glasmacher; A Arns; A Mühling; Katjana Orlopp; Günter Marklein; Marie von Lilienfeld-Toal
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Infection 2008;36(1):54-8.
2007: Marie von Lilienfeld-Toal; Corinna Hahn-Ast; Hartmut Kirchner; Dimitri Flieger; Gottfried Dölken; Axel Glasmacher
A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy.
Haematologica 2007;92(12):1719-20.
2007: Steffen Engelhart; Axel Glasmacher; Arne Simon; Martin Exner
Air sampling of Aspergillus fumigatus and other thermotolerant fungi: comparative performance of the Sartorius MD8 airport and the Merck MAS-100 portable bioaerosol sampler.
International journal of hygiene and environmental health 2007;210(6):733-9.
2007: Iris Breitkreutz; Henk M Lokhorst; Marc S Raab; B van der Holt; Friedrich W Cremer; Doris Herrmann; Axel Glasmacher; Ingo G H Schmidt-Wolf; I W Blau; H Martin; Hans Salwender; A Haenel; Pieter Sonneveld; Hartmut Goldschmidt
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Leukemia 2007;21(6):1294-9.
2007: Marie von Lilienfeld-Toal; Kirsten Midgley; Suzanne Lieberbach; Lorna Barnard; Axel Glasmacher; Maria Gilleece; Gordon Cook
Observation-based early warning scores to detect impending critical illness predict in-hospital and overall survival in patients undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):568-76.
2007: Ulrich Schuler; Susanne Bammer; Walter Aulitzky; Claudia Binder; Angelika Böhme; Gerlinde Egerer; Michael Sandherr; Rainer Schwerdtfeger; Gerda Silling; Hannes Wandt; Axel Glasmacher; Gerhard Ehninger
Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
Onkologie 2007;30(4):185-91.
2007: Marcus Gorschlüter; Axel Glasmacher; Susann Sarazin; Frank Hackbarth; Eckfried Hoebert; Katjana Orlopp; Ingo G H Schmidt-Wolf; Ulrich Mey
CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study.
Leukemia & lymphoma 2007;48(3):506-12.
2007: Franziska Geiser; Corinna Hahn; Rupert Conrad; Reinhard Liedtke; Tilman Sauerbruch; Ingo Schmidt-Wolf; Axel Glasmacher
Interaction of psychological factors and the effect of epoetin-alfa treatment in cancer patients on hemoglobin and fatigue.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(3):273-8.
2007: Arne Simon; Mette Besuden; Sandra Vezmar; Carola Hasan; Dagmar Lampe; Sigrid Kreutzberg; Axel Glasmacher; Udo Bode; Gudrun Fleischhack
Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(2):213-20.
2006: Aixia Wang; Yingyuan Zhang; Lixian He; Zhixiang Shen; Wanqing Liao; Mingzhe Han; Ruoyu Li; Derong Liang; Shaoxi Wu; Corinna Hahn-Ast; Axel Glasmacher; Wai Albert Liekwok
Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
Japanese journal of infectious diseases 2006;59(6):370-6.
2006: Ulrich Mey; Attilio Olivieri; Katjana Orlopp; Christian Rabe; John Strehl; Marcus Gorschlueter; Manfred Hensel; Dimitri Flieger; Axel Glasmacher; Ingo G H Schmidt-Wolf
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.
Leukemia & lymphoma 2006;47(12):2558-66.
2006: Thomas Moehler; Jens Hillengass; Axel Glasmacher; Hartmut Goldschmidt
Thalidomide in multiple myeloma.
Current pharmaceutical biotechnology 2006;7(6):431-40.
2006: Marie von Lilienfeld-Toal; A Schneider; Katjana Orlopp; Corinna Hahn-Ast; Axel Glasmacher; Frank Stüber
Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(12):1241-5.
2006: Ulrich Mey; Katjana Orlopp; Dimitri Flieger; John Strehl; Anthony Ho; Manfred Hensel; Cordula Bopp; Marcus Gorschlüter; Martin Wilhelm; Josef Birkmann; Ulrich Kaiser; Andreas Neubauer; Axel Florschütz; Christian Rabe; Corinna Hahn; Axel Glasmacher; Ingo G H Schmidt-Wolf
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Cancer investigation 2006;24(6):593-600.
2006: Ingo G H Schmidt-Wolf; Axel Glasmacher; Corinna Hahn-Ast; A Jüttner; T Schnurr; Friedrich W Cremer; T Moehler; Hartmut Goldschmidt; B Busert; R Schubert; Gesa Schwanitz
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Cancer genetics and cytogenetics 2006;167(1):20-5.
2006: Marcus Gorschlüter; Ulrich Mey; John Strehl; Michael Schepke; Christof Lamberti; Tilman Sauerbruch; Axel Glasmacher
Cholecystitis in neutropenic patients: retrospective study and systematic review.
Leukemia research 2006;30(5):521-8.
2006: Richard F Schlenk; Stefan Fröhling; Frank Hartmann; J Th Fischer; Axel Glasmacher; F del Valle; K Götze; Christoph Nerl; R Schoch; Hans Pralle; H G Mergenthaler; M Hensel; E Koller; H Kirchen; Axel C Matzdorff; Hans Salwender; H G Biedermann; Stephan Kremers; Detlef Haase; Axel Benner; Konstanze Döhner; Hartmut Döhner
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
Leukemia 2006;20(4):748-50.
2006: Axel Glasmacher; Corinna Hahn; Florian Hoffmann; Ralph Naumann; Hartmut Goldschmidt; Marie von Lilienfeld-Toal; Katjana Orlopp; Ingo Schmidt-Wolf; Marcus Gorschlüter
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.
British journal of haematology 2006;132(5):584-93.
2006: Axel Glasmacher; Oliver A Cornely; Andrew J Ullmann; Ulrich Wedding; Heinrich Bodenstein; Hannes Wandt; Christian Boewer; Rita Pasold; Hans-Heinrich Wolf; Mathias Hänel; Gottfried Dölken; Christian Junghanss; Reinhard Andreesen; Hartmut Bertz
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
The Journal of antimicrobial chemotherapy 2006;57(2):317-25.
2006: Marcus Gorschlüter; Ulrich Mey; John Strehl; Volker Schmitz; Christian Rabe; Katharina Pauls; Carsten Ziske; Ingo G H Schmidt-Wolf; Axel Glasmacher
Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
BMC infectious diseases 2006;6():35.
2006: Selçuk Tasci; Axel Glasmacher; Silvia Lentini; Klaus Tschubel; Santiago Ewig; Ernst Molitor; Tilman Sauerbruch; Berndt Lüderitz; Christian Rabe
Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome.
Mycoses 2006;49(1):37-42.
2006: Axel Glasmacher; Oliver A Cornely; Katjana Orlopp; S Reuter; S Blaschke; M Eichel; Gerda Silling; B Simons; Gerlinde Egerer; M Siemann; M Florek; R Schnitzler; P Ebeling; J Ritter; H Reinel; Philipp Schütt; H Fischer; Corinna Hahn; Gudrun Just-Nuebling
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
The Journal of antimicrobial chemotherapy 2006;57(1):127-34.
2005: C Lamberti; T Sauerbruch; Axel Glasmacher
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
Cancer treatment reviews 2005;31(8):648-52.
2005: Thomas Heinicke; Eva Wardelmann; Tilman Sauerbruch; Henriette J Tschampa; Axel Glasmacher; Holger Palmedo
Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Anticancer research 2005;25(6C):4591-4.
2005: Axel Glasmacher; Marie von Lilienfeld-Toal; S Schulte; Corinna Hahn; Ingo G H Schmidt-Wolf; A Prentice
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11 Suppl 5():17-23.
2005: Axel Glasmacher; Archibald Grant Prentice
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
The Journal of antimicrobial chemotherapy 2005;56 Suppl 1():i23-i32.
2005: Marcus Gorschlüter; Ulrich Mey; John Strehl; Carsten Ziske; Michael Schepke; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Axel Glasmacher
Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
European journal of haematology 2005;75(1):1-13.
2005: Richard F Schlenk; U Germing; Frank Hartmann; Axel Glasmacher; J Th Fischer; F del Valle y Fuentes; K Götze; Hans Pralle; Christoph Nerl; Hans Salwender; Wolfgang Grimminger; A Petzer; M Hensel; Axel Benner; L Zick; Konstanze Döhner; Stefan Fröhling; Hartmut Döhner
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
Leukemia 2005;19(6):978-83.
2005: Klaus Fliessbach; Christoph Helmstaedter; Horst Urbach; A Althaus; Hendrik Pels; Michael Linnebank; A Juergens; Axel Glasmacher; Ingo G H Schmidt-Wolf; Thomas Klockgether; Uwe Schlegel
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Neurology 2005;64(7):1184-8.
2005: Marie von Lilienfeld-Toal; Axel Glasmacher
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
Cancer 2005;103(4):874; discussion 875.
2005: Oliver Bonn; Gabriele Schmidt-Wolf; Frank Risse; Axel Glasmacher; Rolf Kleinschmidt; Ingo G H Schmidt-Wolf
Vindesine and etoposide: A practical and well-tolerated therapy for elderly patients or patients in reduced clinical condition with extensive-stage small-cell lung cancer (SCLC).
Medical science monitor : international medical journal of experimental and clinical research 2005;11(2):PI19-21.
2005: Axel Glasmacher; Marie von Lilienfeld-Toal
The current status of thalidomide in the management of multiple myeloma.
Acta haematologica 2005;114 Suppl 1():3-7.
2004: Richard F Schlenk; Stefan Fröhling; Frank Hartmann; J Th Fischer; Axel Glasmacher; F del Valle; Wolfgang Grimminger; K Götze; C Waterhouse; R Schoch; Hans Pralle; H G Mergenthaler; M Hensel; E Koller; H Kirchen; J Preiss; Hans Salwender; H G Biedermann; Stephan Kremers; F Griesinger; Axel Benner; B Addamo; Konstanze Döhner; Rainer Haas; Hartmut Döhner
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
Leukemia 2004;18(11):1798-803.
2004: Axel Glasmacher
Invasive fungal infections in patients with hematologic malignancies: the next steps.
Supportive cancer therapy 2004;2(1):31-3.
2004: Axel Glasmacher
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma.
Cancer treatment reviews 2004;30(6):577-82.
2004: Marie von Lilienfeld-Toal; M P Dietrich; Axel Glasmacher; L Lehmann; P Breig; Corinna Hahn; Ingo G H Schmidt-Wolf; Günter Marklein; S Schroeder; F Stuber
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(7):539-44.
2004: Michael Linnebank; S Schmidt; Heike Kölsch; Anja Linnebank; Reinhard Heun; Ingo G H Schmidt-Wolf; Axel Glasmacher; Klaus Fliessbach; Thomas Klockgether; Uwe Schlegel; Hendrik Pels
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.
British journal of cancer 2004;90(10):1969-71.
2004: Christian Rabe; Ulrich Mey; Michael Paashaus; Annemarie Musch; Selçuk Tasci; Axel Glasmacher; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Franz Ludwig Dumoulin
Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis.
Journal of critical care 2004;19(1):29-35.
2004: Axel Glasmacher; Hartmut Goldschmidt; Jörg Mezger; Torsten Haferlach; Ingo G H Schmidt-Wolf; Frank Gieseler
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial.
Haematologica 2004;89(3):371-3.
2003: Axel Glasmacher; Archibald Prentice; Marcus Gorschlüter; Steffen Engelhart; Corinna Hahn; Benjamin Djulbegovic; Ingo G H Schmidt-Wolf
Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4615-26.
2003: Hendrik Pels; Ingo G H Schmidt-Wolf; Axel Glasmacher; Holger Schulz; Andreas Engert; Volker Diehl; Anton Zellner; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Marlies Vogt-Schaden; Gerlinde Egerer; Udo Bode; Carlo Schaller; Martina Deckert; Rolf Fimmers; Christoph Helmstaedter; Aslihan Atasoy; Thomas Klockgether; Uwe Schlegel
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4489-95.
2003: John Strehl; Ulrich Mey; Axel Glasmacher; Benjamin Djulbegovic; Christine Mayr; Marcus Gorschlüter; Carsten Ziske; Ingo G H Schmidt-Wolf
High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.
Haematologica 2003;88(11):1304-15.
2003: Carsten Ziske; C Schlie; Marcus Gorschlüter; Axel Glasmacher; Ulrich Mey; John Strehl; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.
British journal of cancer 2003;89(8):1413-7.
2003: Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Axel Glasmacher; Christoph Kahl; Meinolf Karthaus; Winfried Kern; William H Krüger; Georg Maschmeyer; Jörg Ritter; Hans Salwender; Michael Sandherr; Xaver Schiel; Silke Schüttrumpf; Michal Sieniawski; Gerda Silling; Andrew J Ullmann; Hans-Heinrich Wolf
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S186-200.
2003: Hartmut Goldschmidt; Pieter Sonneveld; Friedrich W Cremer; Bronno van der Holt; Petra H M Westveer; Iris Breitkreutz; Axel Benner; Axel Glasmacher; Ingo G H Schmidt-Wolf; H Martin; D Hoelzer; Anthony Ho; Henk M Lokhorst
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
Annals of hematology 2003;82(10):654-9.
2003: Steffen Engelhart; J Hanfland; Axel Glasmacher; Ludmila Krizek; Ingo G H Schmidt-Wolf; Martin Exner
Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions.
The Journal of hospital infection 2003;54(4):300-4.
2003: Marcus Gorschlüter; Corinna Hahn; A Fixson; Ulrich Mey; Carsten Ziske; Ernst Molitor; Regine Horré; Tilman Sauerbruch; Günter Marklein; Ingo G H Schmidt-Wolf; Axel Glasmacher
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(6):362-70.
2003: Hinrich Abken; Andreas Hombach; Günter Reinhard; Angela Märten; Claudia Schlimper; Axel Glasmacher; Thomas Bieber; Ingo G H Schmidt-Wolf
Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.
Leukemia & lymphoma 2003;44(4):583-92.
2003: Klaus Fliessbach; Horst Urbach; Christoph Helmstaedter; Hendrik Pels; Axel Glasmacher; Jürgen A Kraus; Thomas Klockgether; Ingo Schmidt-Wolf; Uwe Schlegel
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Archives of neurology 2003;60(4):563-8.
2003: Axel Glasmacher
High dose therapy may have no survival benefit over CHOEP primary chemotherapy for people with aggressive non-Hodgkin's lymphoma.
Cancer treatment reviews 2003;29(2):139-42.
2003: Andreas H Groll; Juan Gea-Banacloche; Axel Glasmacher; Gudrun Just-Nuebling; Georg Maschmeyer; THOMAS WALSH
Clinical pharmacology of antifungal compounds.
Infectious disease clinics of North America 2003;17(1):159-91, ix.
2003: Ulrich Mey; Marcus Gorschlüter; Carsten Ziske; Rolf Kleinschmidt; Axel Glasmacher; Ingo G H Schmidt-Wolf
Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.
Anti-cancer drugs 2003;14(3):233-8.
2003: Ulrich Mey; Axel Glasmacher; Corinna Hahn; Marcus Gorschlüter; Carsten Ziske; M Mergelsberg; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(3):148-55.
2003: Ulrich Mey; John Strehl; Marcus Gorschlüter; Carsten Ziske; Axel Glasmacher; Hans Pralle; Ingo Schmidt-Wolf
Advances in the treatment of hairy-cell leukaemia.
The lancet oncology 2003;4(2):86-94.
2002: Carsten Ziske; Marcus Gorschlüter; Ulrich Mey; Ruth Offergeld; Axel Glasmacher; Ingo G H Schmidt-Wolf
Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
Anticancer research 2002;22(6B):3723-6.
2002: Steffen Engelhart; Ludmila Krizek; Axel Glasmacher; E Fischnaller; Günter Marklein; Martin Exner
Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment.
The Journal of hospital infection 2002;52(2):93-8.
2002: Steffen Engelhart; Axel Glasmacher; Martin Exner; Michael H Kramer
Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(5):244-8.
2002: Marcus Gorschlüter; Günter Marklein; Katja Höfling; Ricarda Clarenbach; Stefanie Baumgartner; Corinna Hahn; Carsten Ziske; Ulrich Mey; Ricarda Heller; Anna Maria Eis-Hübinger; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Axel Glasmacher
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology.
British journal of haematology 2002;117(2):351-8.
2002: Frank Kaufmann; Steffen Engelhart; Axel Glasmacher; Martin Exner
[Risk of infection and preventative strategies in the domestic environment of immunosuppressed hematologic oncology patients].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(1):22-9.
2002: Marcus Gorschlüter; Corinna Hahn; Carsten Ziske; Ulrich Mey; Björn Schöttker; Ernst Molitor; S Becker; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Axel Glasmacher
Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia.
Infection 2002;30(1):22-5.
2001: Marie von Lilienfeld-Toal; O Ebert; Ingo Theuerkauf; Axel Glasmacher; Ingo G H Schmidt-Wolf
Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?
Annals of hematology 2001;80(10):611-3.
2001: Angela Märten; Sabine Renoth; Marie von Lilienfeld-Toal; Peter Buttgereit; Frank Schakowski; Axel Glasmacher; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.
Haematologica 2001;86(10):1029-37.
2001: Marcus Gorschlüter; Axel Glasmacher; Corinna Hahn; Frank Schakowski; Carsten Ziske; Ernst Molitor; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Clostridium difficile infection in patients with neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(6):786-91.
2001: Steffen Engelhart; Axel Glasmacher; Frank Kaufmann; Martin Exner
Protecting vulnerable groups in the home: the interface between institutions and the domestic setting.
The Journal of infection 2001;43(1):57-9; discussion 59-60.
2001: Uwe Schlegel; Hendrik Pels; Axel Glasmacher; Rolf Kleinschmidt; Ingo Schmidt-Wolf; Christoph Helmstaedter; Klaus Fliessbach; Martina Deckert; Dirk Van Roost; Rolf Fimmers; Udo Bode; Thomas Klockgether
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
Journal of neurology, neurosurgery, and psychiatry 2001;71(1):118-22.
2001: Marcus Gorschlüter; Axel Glasmacher; Corinna Hahn; Claudia C Leutner; Günter Marklein; J Remig; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
Severe abdominal infections in neutropenic patients.
Cancer investigation 2001;19(7):669-77.
2000: Claudia C Leutner; Jürgen Gieseke; Götz Lutterbey; Christiane Kuhl; Axel Glasmacher; Eva Wardelmann; Albert Theisen; Hans H Schild
MR imaging of pneumonia in immunocompromised patients: comparison with helical CT.
AJR. American journal of roentgenology 2000;175(2):391-7.
2000: Hendrik Pels; M Deckert-Schlüter; Axel Glasmacher; Rolf Kleinschmidt; RD Oehring; H P Fischer; Udo Bode; Uwe Schlegel
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
Hematological oncology 2000;18(1):21-32.
2000: christian scheffold; Björn Schöttker; P Lefterova; M Csipai; Axel Glasmacher; Dieter Huhn; Andreas Neubauer; Ingo G H Schmidt-Wolf
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
Acta haematologica 2000;104(2-3):72-9.
1999: Claudia C Leutner; Jürgen Gieseke; Götz Lutterbey; Christiane Kuhl; Sebastian Flacke; Axel Glasmacher; Albert Theisen; Eva Wardelmann; C Grohe; Hans H Schild
[MRT versus CT in the diagnosis of pneumonias: an evaluation of a T2-weighted ultrafast turbo-spin-echo sequence (UTSE)].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1999;170(5):449-56.
1999: Axel Glasmacher; Corinna Hahn; Ernst Molitor; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Mycoses 1999;42(11-12):591-600.
1999: Axel Glasmacher; Corinna Hahn; Claudia C Leutner; Ernst Molitor; Eva Wardelmann; C Losem; Tilman Sauerbruch; Günter Marklein; Ingo G H Schmidt-Wolf
Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
Mycoses 1999;42(7-8):443-51.
1999: Axel Glasmacher; Corinna Hahn; Ernst Molitor; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Günter Marklein
Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Mycoses 1999;42(5-6):395-402.
1998: Axel Glasmacher; Ernst Molitor; Corinna Hahn; K Bomba; Santiago Ewig; Claudia C Leutner; Eva Wardelmann; Ingo G H Schmidt-Wolf; Jörg Mezger; Günter Marklein; Tilman Sauerbruch
Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Leukemia 1998;12(9):1338-43.
1998: R Schiemann; Axel Glasmacher; E Bailly; Regine Horré; Ernst Molitor; Claudia C Leutner; M T Smith; Rolf Kleinschmidt; Günter Marklein; Tilman Sauerbruch
Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature.
Mycoses 1998;41(3-4):113-6.
1998: Axel Glasmacher; G Just-Nübling; Ernst Molitor
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Deutsche medizinische Wochenschrift (1946) 1998;123(7):191-4.
1998: Axel Glasmacher; Günter Marklein; G Just-Nübling; Claudia C Leutner; Santiago Ewig
[Diagnosis of invasive mycoses in neutropenic patients with systemic hematologic diseases].
Deutsche medizinische Wochenschrift (1946) 1998;123(6):157-60.
1997: Axel Glasmacher; Torsten Haferlach; Marcus Gorschlüter; Jörg Mezger; C Maintz; M R Clemens; Y Ko; Corinna Hahn; R Ubelacker; Rolf Kleinschmidt; Frank Gieseler
Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma.
Leukemia 1997;11 Suppl 5():S22-6.
1997: Claudia C Leutner; Holger Strunk; H Müller-Miny; Santiago Ewig; Axel Glasmacher; C Losem; Ernst Molitor; Hans H Schild
[The typical radiological findings and course of invasive pulmonary aspergillosis in the immunosuppressed patient].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1997;167(1):24-31.
1997: Marcus Gorschlüter; Axel Glasmacher; Frank Risse; Burkhard Klein; Hans-Ulrich Klehr; Jörg Mezger
Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(3):593-5.
1996: Jörg Mezger; Peter Malfertheiner; Axel Glasmacher; T H Breuer; Hans-Peter Fischer; M Meybehm; H J Kipnowski; Tilman Sauerbruch
[Libyan patient with chronic diarrhea].
Zeitschrift für Gastroenterologie 1996;34(10):699-703.
1996: J Mezger; Axel Glasmacher
[Pro and contra adjuvant chemotherapy in colorectal carcinoma].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(9):609-11.
1996: Axel Glasmacher; Ernst Molitor; Jörg Mezger; Günter Marklein
Antifungal prophylaxis with itraconazole in neutropenic patients: pharmacological, microbiological and clinical aspects.
Mycoses 1996;39(7-8):249-58.
1996: Frank Gieseler; Axel Glasmacher; D Kämpfe; H Wandt; Volkmar Nuessler; S Valsamas; J Kunze; K Wilms
Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Leukemia 1996;10(7):1177-80.
1996: Frank Gieseler; Axel Glasmacher; D Kämpfe; H Wandt; Volkmar Nuessler; S Valsamas; J Kunze; K Wilms
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Leukemia 1996;10 Suppl 3():S46-S49.
1995: Jörg Mezger; Axel Glasmacher; Tilman Sauerbruch
[Aftercare in patients with colorectal carcinomas].
Deutsche medizinische Wochenschrift (1946) 1995;120(45):1549-54.
1993: W Dieter Paar; F J Wieres; D Bösche; Axel Glasmacher; H J Dengler
[Pharmacokinetics of colloidal bismuth subcitrate. Solution versus tablet].
Arzneimittel-Forschung 1993;43(11):1189-92.
1991: Juergen Bux; G M Robertz-Vaupel; Axel Glasmacher; H J Dengler; C Mueller-Eckhardt
Autoimmune neutropenia due to NA1 specific antibodies in primary biliary cirrhosis.
British journal of haematology 1991;77(1):121-2.
1990: G M Robertz-Vaupel; Axel Glasmacher; J Vogel; H A Vaupel; O Köster; Luciano Pizzulli
[Primary bilateral, adrenal, highly malignant B-cell lymphoma with lymphoblastic mengiosis].
Klinische Wochenschrift 1990;68(21):1076-81.